BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2019
View Archived Issues
Crystal structures may provide crystal ball for anti-TB drugs
Read More
Trial results reported for ublituximab, umbralisib and ibrutinib combination in B-cell malignancies
Read More
Resistin promotes VEGF-A expression and angiogenesis in chondrosarcoma through inhibition of a miRNA
Read More
Sylentis presents results from phase III HELIX study of tivanisiran
Read More
Bayer and Kyoto University form new research alliance in pulmonology
Read More
Veru initiates phase Ib/II study of VERU-111 in advanced mCRPC
Read More
Vanderbilt University describes muscarinic acetylcholine M4 receptor antagonists
Read More
New 5-HT-2A antagonists idenified at Tonix Pharmaceuticals
Read More
Syros Pharmaceuticals describes TAM receptor tyrosine kinase inhibitors
Read More
Ohio State University, Brigham and Women's Hospital patent SLC1A2 activators
Read More
Innate Tumor Immunity presents NACHT, LRR and PYD domains-containing protein 3 agonists
Read More
New bromodomain-containing protein 4 inhibitors reported by Zhejiang Hisun Pharmaceutical
Read More
Metrion Biosciences and LifeArc to collaborate on ion channel drug discovery project
Read More
Phase I results for LMB-100 plus nab-paclitaxel in pancreatic adenocarcinoma
Read More
Invenra, Wisconsin Alumni Research Foundation enter neuroblastoma collaboration
Read More
VEE TC-83 vaccine demonstrates safety in phase II study
Read More
Nanobiotix presents clinical data for NBTXR-3 in patients with HCC and liver metastasis
Read More
Theravance Biopharma presents novel dual AT1 antagonist/NEP inhibitor, TD-0212
Read More
Lacosamide shows promise in patients with Nav1.7-related small fiber neuropathy
Read More
Ipafricept found safe in patients with stage IV pancreatic cancer
Read More
MeiraGTx and Janssen collaborate on gene therapies for inherited retinal diseases
Read More
New pilot study of donor CMV-specific CTLs to treat CMV infection in transplant patients
Read More